NO990498D0 - 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon - Google Patents

19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon

Info

Publication number
NO990498D0
NO990498D0 NO990498A NO990498A NO990498D0 NO 990498 D0 NO990498 D0 NO 990498D0 NO 990498 A NO990498 A NO 990498A NO 990498 A NO990498 A NO 990498A NO 990498 D0 NO990498 D0 NO 990498D0
Authority
NO
Norway
Prior art keywords
cholansteroids
change
hypothalamic function
human hypothalamic
neurochemical initiators
Prior art date
Application number
NO990498A
Other languages
English (en)
Other versions
NO990498L (no
Inventor
Clive Jennings-White
David Berliner
Nathan W Adams
Original Assignee
Pherin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Pharm Inc filed Critical Pherin Pharm Inc
Publication of NO990498L publication Critical patent/NO990498L/no
Publication of NO990498D0 publication Critical patent/NO990498D0/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
    • H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
    • H01L21/027—Making masks on semiconductor bodies for further photolithographic processing not provided for in group H01L21/18 or H01L21/34

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Manufacturing & Machinery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Computer Hardware Design (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Power Engineering (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO990498A 1996-06-07 1999-02-03 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon NO990498D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/660,804 US5922699A (en) 1996-06-07 1996-06-07 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
PCT/US1997/009992 WO1997046574A1 (en) 1996-06-07 1997-06-09 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function

Publications (2)

Publication Number Publication Date
NO990498L NO990498L (no) 1999-02-03
NO990498D0 true NO990498D0 (no) 1999-02-03

Family

ID=24651031

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990498A NO990498D0 (no) 1996-06-07 1999-02-03 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon

Country Status (11)

Country Link
US (3) US5922699A (no)
EP (1) EP0948521A4 (no)
KR (1) KR20010013101A (no)
AU (1) AU732960B2 (no)
BG (1) BG62936B1 (no)
CA (1) CA2258177C (no)
HU (1) HUP9903432A3 (no)
NO (1) NO990498D0 (no)
NZ (1) NZ333548A (no)
PL (1) PL331522A1 (no)
WO (1) WO1997046574A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922699A (en) 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
BR9711812A (pt) * 1996-07-23 1999-08-24 Pherin Pharm Inc EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade
FR2791572A1 (fr) * 1999-03-31 2000-10-06 Adir Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables
US6806293B1 (en) * 2001-03-12 2004-10-19 Darley Pharmaceuticals Ltd Use of pheromone compounds having MAP kinase modulating activity
CA2451992C (en) 2001-05-15 2013-08-27 Psychogenics Inc. Systems and methods for monitoring behavior informatics
DE10335845B4 (de) * 2003-05-09 2006-08-31 Müller, Martina, Dr.med. Pheromone als Antikrebsmittel
EP1789056A1 (en) * 2004-06-29 2007-05-30 Jado Technologies GmbH Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts
US20070048230A1 (en) * 2005-08-24 2007-03-01 Walter Parsadayan Pheromone compositions and methods
DE102020204507A1 (de) 2020-04-07 2021-10-07 Henkel Ag & Co. Kgaa Weichspüler mit aphrodisierend wirkenden Duftstoffen
DE102020204506A1 (de) 2020-04-07 2021-10-07 Henkel Ag & Co. Kgaa Weichspüler mit Pheromonen
DE102020204509A1 (de) 2020-04-07 2021-10-07 Henkel Ag & Co. Kgaa Waschmittel mit Pheromonen
DE102020204505A1 (de) 2020-04-07 2021-10-07 Henkel Ag & Co. Kgaa Wasch-/Pflegeartikel umfassend Pheromone

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH455765A (de) * 1958-04-12 1968-05-15 Philips Nv Verfahren zur Herstellung neuer Steroide
US3492318A (en) 1968-01-22 1970-01-27 Syntex Corp Cyclopropenyl androstanes
US3946052A (en) 1975-06-16 1976-03-23 Stanford Research Institute 19-Norpregna- 1,3,5(10)-trien-3-ol and loweralkyl homologs thereof having postcoital antifertility activity
US5155045A (en) 1985-01-25 1992-10-13 Trustees Of The University Of Penn. Use of male essence to alter female endocrine response
US5223492A (en) * 1987-10-27 1993-06-29 Nasraoui Nejib M Derivatives of 19-nor progesterone; process for producing them and the pharmaceutical compositions incorporating them
FR2637803B1 (fr) * 1988-10-19 1993-07-09 Ire Celltarg Sa Ligands specifiques de recepteurs d'hormones steroides estrogenes et progestagenes, application et produits intermediaires de synthese
JP2578369B2 (ja) 1989-05-09 1997-02-05 ポーラ化成工業株式会社 芳香組成物
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones
AU698834B2 (en) * 1993-05-24 1998-11-12 Purdue Pharma Ltd. Methods and compositions for inducing sleep
BR9307866A (pt) * 1993-06-15 1996-07-30 Pherin Corp Esteróides estreno como iniciadores neuroquímicos de mudança em funçao hipotalamica humana e composiçoes farmaceuticas relacionadas e processos
ES2210243T3 (es) * 1993-06-15 2004-07-01 Pherin Corporation Esteroides de androstano utiles como iniciadores del cambio de la funcion hipotalamica humana, composiciones farmaceuticas y procedimientos asociados.
KR970700199A (ko) * 1994-01-06 1997-01-08 에드워드 이. 데이비스 신규한 항남성호르몬제 및 이와 관련된 조성물 및 사용방법(novel antiandrogenic agents and related pharmaceutical compositions and methods of use)
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
NZ294510A (en) * 1994-09-29 1999-04-29 Pherin Corp Estrene steroids which bind to neuroepithelial receptors changing hypothalamic function
WO1996040421A1 (en) 1995-06-07 1996-12-19 Memtec America Corporation Microfiltration membranes having high pore density and mixed isotropic and anisotropic structure
US5922699A (en) 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
BR9711812A (pt) * 1996-07-23 1999-08-24 Pherin Pharm Inc EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade

Also Published As

Publication number Publication date
BG103060A (en) 1999-10-29
AU732960B2 (en) 2001-05-03
US5922699A (en) 1999-07-13
KR20010013101A (ko) 2001-02-26
US6437156B1 (en) 2002-08-20
WO1997046574A1 (en) 1997-12-11
HUP9903432A3 (en) 2000-04-28
PL331522A1 (en) 1999-07-19
NO990498L (no) 1999-02-03
CA2258177C (en) 2007-05-08
EP0948521A4 (en) 2007-01-31
HUP9903432A2 (hu) 2000-03-28
EP0948521A1 (en) 1999-10-13
NZ333548A (en) 2000-06-23
CA2258177A1 (en) 1997-12-11
BG62936B1 (bg) 2000-11-30
US6432938B1 (en) 2002-08-13
AU3307397A (en) 1998-01-05

Similar Documents

Publication Publication Date Title
IS4970A (is) Setnar 6,6-heteró-bísýklískar afleiður
IS1995B (is) Tríazól afleiður, gagnlegar í meðhöndlun
DE69838405D1 (de) Mikrostrukturierte, kosmetisch verträgliche Zusamensetzungen
IT1285134B1 (it) Compressore alternativo.
FI950715A0 (fi) Ytmikromekanisk, symmetrisk tryckskillnadsgivare
DK0922050T3 (da) 3-Descladinose-2,3-anhydroerythromycin-derivater
NO990498D0 (no) 19-nor-cholansteroider som neurokjemiske initiatorer av forandring i human, hypotalamisk funksjon
NO960499L (no) Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner
BR9506389B1 (pt) composto de silìcio, e, composição dietética, cosmética e terapêutica.
DK0874814T3 (da) 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler
ATE198192T1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
NO970472L (no) Preganer og cholaner som neurokjemiske intiatorer av forandring i hypotalamusfunksjon
ATE240941T1 (de) 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate
FI972860A (fi) Roottoreita
ES1032571Y (es) Gafa,
FR2752699B1 (fr) Boitier, du type boitier de maquillage
FI972885A0 (fi) Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
FI951664A0 (fi) Oeverkast foer med armstoed foersedda soffor, faotoeljer eller motsvarande
ES1035559Y (es) Carteraporta-objeto ocultable.
FI962387A0 (fi) Foerfarande foer framstaellning av 1,4-butandiol
FI962118A0 (fi) Foerbaettrad anordning foer behandling av roekgaser, saerskilt avgaser
FI1920U1 (fi) Torkugn, foer torkning av maolade eller pao annat liknande saett behandlade delar
DE29514181U1 (de) Lottodecodierer, synchronisiert
ES1032559Y (es) Perfeccionamientos introducidos en la construccion de edificios.
FI1391U1 (fi) Utrymme, saosom bastu av elementkonstruktion

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application